Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less ...

Emalex Biosciences’ dopamine blocker led to fewer patients with Tourette syndrome relapsing in a phase 3 trial, setting the ...

Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies.

A person’s precious organ donation came with an unexpected visitor. In a new paper out this month, scientists have documented ...

Daughter’s school sports day led to man’s heartbreaking incurable diagnosis - The 44-year-old hopes to travel to Mexico in ...

A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis ...

Losing weight isn’t just about cutting calories—it’s a comprehensive health journey. Dr. Bharti Shetye, also known as Dr.

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

As spring farming begins across the country, China released its annual rural policy blueprint on Sunday, referred to as the ...

Kesimpta was approved in August 2020 as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing ...